The IL-1 family was reported to preferentially express in TNBC and be involved in the development of breast cancer, while inhibition of interleukin 1 receptor (IL-1R) affected the proliferation, prevented the tumor progression and metastasis [47, 48]. Here, IL1A is linked to breast carcinoma.